Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,763 | -63,698 | -19,976 | 51,958 | 37,637 |
| Depreciation Amortization | 1,724 | 863 | 3,936 | 2,910 | 2,245 |
| Income taxes - deferred | 0 | 0 | N/A | 4,772 | N/A |
| Accounts receivable | -688 | 138 | -172 | -145 | 631 |
| Other Working Capital | -1,353 | -869 | 2,478 | 945 | 1,433 |
| Other Operating Activity | 50,342 | 53,228 | -16,783 | -85,282 | -59,107 |
| Operating Cash Flow | $-17,738 | $-10,338 | $-30,517 | $-24,842 | $-17,161 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -237 | -198 | -1,126 | -744 | -474 |
| Purchase Of Investment | N/A | N/A | -189 | N/A | N/A |
| Sale Of Investment | 3,215 | 3,215 | N/A | 0 | N/A |
| Other Investing Activity | -808 | -806 | -8,910 | -8,898 | -8,910 |
| Investing Cash Flow | $2,170 | $2,211 | $-10,225 | $-9,642 | $-9,384 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 425 | 384 | 299 |
| Debt Repayment | -151 | -97 | -253 | -31 | -31 |
| Common Stock Issued | 5,737 | 737 | 59,707 | 30,122 | 20,154 |
| Common Stock Repurchased | -51 | -7 | -888 | 0 | -31 |
| Other Financing Activity | 0 | 0 | -3,600 | -1,463 | 3,629 |
| Financing Cash Flow | $5,535 | $633 | $55,391 | $29,012 | $24,020 |
| Exchange Rate Effect | -21 | 60 | 101 | 46 | 87 |
| Beginning Cash Position | 37,685 | 37,685 | 22,935 | 22,935 | 22,935 |
| End Cash Position | 27,631 | 30,251 | 37,685 | 17,509 | 20,497 |
| Net Cash Flow | $-10,054 | $-7,434 | $14,750 | $-5,426 | $-2,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,738 | -10,338 | -30,517 | -24,842 | -17,161 |
| Capital Expenditure | -237 | -198 | -1,326 | -930 | -474 |
| Free Cash Flow | -17,975 | -10,536 | -31,843 | -25,772 | -17,635 |